Scientists have discovered that mRNA cancer vaccines can activate an unexpected type of immune cell, revealing a previously unknown backup system that helps strengthen the body’s attack against tumors. This finding challenges the long-held belief that these vaccines rely on only one immune pathway to trigger anti-cancer responses. By understanding how this additional immune mechanism works, researchers hope to design more effective mRNA cancer vaccines and tailor treatments to individual patients. Although further research is needed, the discovery could improve future cancer immunotherapies and enhance the effectiveness of personalized cancer treatment.
Read more at ScienceDaily